bluebird bio Inc. (BLUE) Drops 5.54% on January 15

Equities Staff |

bluebird bio Inc. (BLUE) was one of the Russell 2000's biggest losers for Friday January 15 as the stock slid 5.54% to $43.99, a loss of $-2.58 per share. Starting at an opening price of $44.50 a share, the stock traded between $42.57 and $46.33 over the course of the trading day. Volume was 961,876 shares over 11,475 trades, against an average daily volume of 1.57 million shares and a total float of 36.68 million.

The losses send bluebird bio Inc. down to a market cap of $1.61 billion. In the last year, bluebird bio Inc. has traded between $197.35 and $42.16, and its 50-day SMA is currently $68.98 and 200-day SMA is $121.67.

bluebird bio Inc is a clinical-stage biotechnology company. It is engaged in developing potentially transformative gene therapies for severe genetic and rare diseases and in the field of T cell-based immunotherapy.

bluebird bio Inc. is based out of Cambridge, MA and has some 207 employees. Its CEO is Nick Leschly.

For a complete fundamental analysis analysis of bluebird bio Inc., check out Equities.com’s Stock Valuation Analysis report for BLUE. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

MGX Minerals Inc.

MGX Minerals is a diversified Canadian mining company listed on the Canadian Securities Exchange. MGX is engaged in the acquisition and development of industrial mineral deposits in western Canada that…

Private Markets

Snapchat

Snapchat is the fastest way to share a moment with friends. The mobile app, allows users to not only share photos with friends but also control how long they can…

GoCoin

Blockchain currencies (e.g. Bitcoin) provide a new disruptive way to transfer value between parties over the internet as opposed to going through banks. GoCoin provides online merchants with a suite…